Cargando…

The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex

Understanding the molecular pathways disrupted in motor neuron diseases is urgently needed. Here, we employed CRISPR knockout (KO) to investigate the functions of four ALS-causative RNA/DNA binding proteins (FUS, EWSR1, TAF15 and MATR3) within the RNAP II/U1 snRNP machinery. We found that each of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Binkai, O’Connell, Jeremy D, Iocolano, Alexander D, Coady, Jordan A, Yu, Yong, Gangopadhyay, Jaya, Gygi, Steven P, Reed, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294556/
https://www.ncbi.nlm.nih.gov/pubmed/30398641
http://dx.doi.org/10.1093/nar/gky1093
_version_ 1783380750672855040
author Chi, Binkai
O’Connell, Jeremy D
Iocolano, Alexander D
Coady, Jordan A
Yu, Yong
Gangopadhyay, Jaya
Gygi, Steven P
Reed, Robin
author_facet Chi, Binkai
O’Connell, Jeremy D
Iocolano, Alexander D
Coady, Jordan A
Yu, Yong
Gangopadhyay, Jaya
Gygi, Steven P
Reed, Robin
author_sort Chi, Binkai
collection PubMed
description Understanding the molecular pathways disrupted in motor neuron diseases is urgently needed. Here, we employed CRISPR knockout (KO) to investigate the functions of four ALS-causative RNA/DNA binding proteins (FUS, EWSR1, TAF15 and MATR3) within the RNAP II/U1 snRNP machinery. We found that each of these structurally related proteins has distinct roles with FUS KO resulting in loss of U1 snRNP and the SMN complex, EWSR1 KO causing dissociation of the tRNA ligase complex, and TAF15 KO resulting in loss of transcription factors P-TEFb and TFIIF. However, all four ALS-causative proteins are required for association of the ASC-1 transcriptional co-activator complex with the RNAP II/U1 snRNP machinery. Remarkably, mutations in the ASC-1 complex are known to cause a severe form of Spinal Muscular Atrophy (SMA), and we show that an SMA-causative mutation in an ASC-1 component or an ALS-causative mutation in FUS disrupts association between the ASC-1 complex and the RNAP II/U1 snRNP machinery. We conclude that ALS and SMA are more intimately tied to one another than previously thought, being linked via the ASC-1 complex.
format Online
Article
Text
id pubmed-6294556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62945562018-12-21 The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex Chi, Binkai O’Connell, Jeremy D Iocolano, Alexander D Coady, Jordan A Yu, Yong Gangopadhyay, Jaya Gygi, Steven P Reed, Robin Nucleic Acids Res Molecular Biology Understanding the molecular pathways disrupted in motor neuron diseases is urgently needed. Here, we employed CRISPR knockout (KO) to investigate the functions of four ALS-causative RNA/DNA binding proteins (FUS, EWSR1, TAF15 and MATR3) within the RNAP II/U1 snRNP machinery. We found that each of these structurally related proteins has distinct roles with FUS KO resulting in loss of U1 snRNP and the SMN complex, EWSR1 KO causing dissociation of the tRNA ligase complex, and TAF15 KO resulting in loss of transcription factors P-TEFb and TFIIF. However, all four ALS-causative proteins are required for association of the ASC-1 transcriptional co-activator complex with the RNAP II/U1 snRNP machinery. Remarkably, mutations in the ASC-1 complex are known to cause a severe form of Spinal Muscular Atrophy (SMA), and we show that an SMA-causative mutation in an ASC-1 component or an ALS-causative mutation in FUS disrupts association between the ASC-1 complex and the RNAP II/U1 snRNP machinery. We conclude that ALS and SMA are more intimately tied to one another than previously thought, being linked via the ASC-1 complex. Oxford University Press 2018-12-14 2018-11-06 /pmc/articles/PMC6294556/ /pubmed/30398641 http://dx.doi.org/10.1093/nar/gky1093 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Molecular Biology
Chi, Binkai
O’Connell, Jeremy D
Iocolano, Alexander D
Coady, Jordan A
Yu, Yong
Gangopadhyay, Jaya
Gygi, Steven P
Reed, Robin
The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title_full The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title_fullStr The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title_full_unstemmed The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title_short The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
title_sort neurodegenerative diseases als and sma are linked at the molecular level via the asc-1 complex
topic Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294556/
https://www.ncbi.nlm.nih.gov/pubmed/30398641
http://dx.doi.org/10.1093/nar/gky1093
work_keys_str_mv AT chibinkai theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT oconnelljeremyd theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT iocolanoalexanderd theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT coadyjordana theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT yuyong theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT gangopadhyayjaya theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT gygistevenp theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT reedrobin theneurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT chibinkai neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT oconnelljeremyd neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT iocolanoalexanderd neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT coadyjordana neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT yuyong neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT gangopadhyayjaya neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT gygistevenp neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex
AT reedrobin neurodegenerativediseasesalsandsmaarelinkedatthemolecularlevelviatheasc1complex